Because the Kv7 family is a newly emerging target in pharmacology, and because Kv7.5 is the latest family member to be analyzed, further studies are required to evaluate Kv7.5 and its roles in various stages of cancer, including metastasis, proliferation, and angiogenesis. Here, KCNQ5 is linked to cancer.